Evidence map›Paper›PMID 37215422›Full record

ArticleWorld journal of clinical cases2023

Association of C-reactive protein and complement factor H gene polymorphisms with risk of lupus nephritis in Chinese population.

Qiu-Yu Li, Jian-Min Lv, Xiao-Ling Liu, Hai-Yun Li, Feng Yu

Open access · diamondAbstract read
In one paragraph

Article in World journal of clinical cases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qiu-Yu LiDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China.
Jian-Min LvSchool of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.
Xiao-Ling LiuSchool of Life Sciences, Lanzhou University, Lanzhou 730000, Gansu Province, China.
Hai-Yun LiSchool of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China. lihaiy@xjtu.edu.cn.
Feng YuDepartment of Medicine, Peking University First Hospital, Beijing 100034, China.
Lanzhou University · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComplement overactivation is a major driver of lupus nephritis (LN). Impaired interactions of C-reactive protein (CRP) with complement factor H (CFH) have been shown as a pathogenic mechanism that contributes to the overactivation of complement in LN. However, genetic variations of neither CRP nor CFH show consistent influences on the risk of LN.

aimTo examine whether genetic variations of CRP and CFH in combination can improve the risk stratification in Chinese population.

methodsWe genotyped six CRP single nucleotide polymorphisms (SNPs) (rs1205, rs3093062, rs2794521, rs1800947, rs3093077, and rs1130864) and three CFH SNPs (rs482934, rs1061170, and rs1061147) in 270 LN patients and 303 healthy subjects.

resultsNo linkage was found among CRP and CFH SNPs, indicating lack of genetic interactions between the two genes. Moreover, CRP and CFH SNPs, neither individually nor in combination, are associated with the risk or clinical manifestations of LN. Given the unambiguous pathogenic roles of the two genes.

conclusionThese findings suggest that the biological effects of most genetic variations of CRP and CFH on their expressions or activities are not sufficient to influence the disease course of LN.

Indexed as

Complement factor HC-reactive proteinLupus nephritisSingle nucleotide polymorphism.Systemic lupus erythematosus

Identifiers

PMID37215422
PMCPMC10198093
OpenAlexW4366814210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.